Intelligent Bio Solutions Ships First Drug Screening Readers Under Syrma Johari Manufacturing Partnership

Intelligent Bio Solutions Inc. -11.86%

Intelligent Bio Solutions Inc.

INBS

2.75

-11.86%

Intelligent Bio Solutions Inc. has begun shipping its first Intelligent Fingerprinting Drug Screening Readers manufactured through a strategic partnership with Syrma Johari MedTech Ltd., a move aimed at scaling production ahead of a planned U.S. market entry in 2026. The company said the collaboration is expected to cut annual production costs by more than 40% and improve gross margins by about 20 percentage points per year, with the new manufacturing capacity providing roughly four times its previous output.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Intelligent Bio Solutions Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202602250845PRIMZONEFULLFEED9660762) on February 25, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.